期刊文献+

磷酸神经鞘氨醇在人结肠癌中的表达及其判断结肠癌预后的研究 被引量:2

Research on the expression of s1p in colon cancer and its prognosis
原文传递
导出
摘要 目的利用人结肠癌标本检测磷酸神经鞘氨醇(sphingosine 1-phosphate,s1p)及其相关激酶sphk1、sphk2的表达,研究其作为血清标记物判断结肠癌预后肿瘤标志物的价值。方法利用real-time PCR检测s1p及其相关激酶sphk1、sphk2的表达,免疫组织化学染色检测蛋白的表达及定位,并利用线性相关性分析及Kaplan-Meier曲线分析结肠癌患者血清s1p与预后的关系。结果 s1p及其受体相关激酶在人结肠癌中表达增高;sphk1在结肠癌组织中高表达;sphk2在正常组织中高表达,在结肠癌组织中表达下降;s1p的表达与sphk1呈正相关,而与sphk2的表达呈负相关;血清s1p的表达与患者的预后呈负相关。结论 s1p在结肠癌中高表达,是判断结肠癌患者术后差的生物标志物。 Objective To investigate the expression of sphingosine 1- phosphate( s1p),and the expressions of the related kinases sphk1 and sphk2 in human colon cancer,and to study the value of serum marker in judging the prognosis of colon cancer.Methods The expressions of s1 p and its related kinases sphk1 and sphk2 in human colon cancer were determined by real-time PCR,and the distribution and protein localization were determined by immunohistochemistry,and the relation between serum s1 p and prognosis of post- surgery gastric patients was analyzed by Kaplan- Meier curve. Results Expressions of s1 p and its related kinases in human colon cancer increased; sphk2 highly expressed in normal issues and decreased in expression in colon cancer; The expression of s1 P was positively correlated with sphk1,but negatively correlated with the expression of sphk2.Serum s1 p was negatively related to prognosis of post- surgery cancer patients. Conclusion s1 p was overexpressed within human colon cancer,and can serve as an indicator of poor prognosis of post- surgery gastric cancer patients.
出处 《中国卫生检验杂志》 CAS 2016年第2期256-259,共4页 Chinese Journal of Health Laboratory Technology
关键词 磷酸神经鞘氨醇 结肠癌 预后 Sphingosine 1-phosphate Colon cancer Prognosis
  • 相关文献

参考文献12

  • 1Arlt O, Sehwiebs A, Japtok L, et al. Sphingosine -1 -phosphate modulates dendritic cell function: focus on non - migratory effects in vitro and in vivo[J]. Cell Physiol Biochem, 2014, 34 (1): 27 -44.
  • 2Kono M, Proia RL. Imaging S1P1 activation in vivo[J]. Exp Cell Res, 2015, 333(2) : 178 -182.
  • 3Zhao J, Garcia D, Gartung A, et al. Sphingosine - 1 - phosphate receptor subtype 2 signaling in endothelial senescence - associated functional impairments and inflammation [ J ]. Curr Atheroscler Rep, 2015, 17(5) : 504.
  • 4Carr JM, Mahalingam S, Bonder CS, et al. Sphingosine kinase 1 inviral infections[J]. Rev Med Virol, 2013, 23(2) : 73 -84.
  • 5Ghi H. Sphingosine - 1 - phosphate and immune regulation : traffic- king and beyond[J]. Trends Pharmaeol Sci, 2011, 32(1) : 16 - 24.
  • 6Cusack KP, Stoffel RH. S1P( 1 ) receptor agonists: Assessment of selectivity and current clinical activity[ J ]. Curr Opin Drug Diseov Devel, 2010, 13(4) : 481 -488.
  • 7Adada M, Canals D, Hannun YA, et al. Sphingosine - 1 - phos- phate receptor 2[J]. FEBS J, 2013, 280(24): 6354-6366.
  • 8Adan - Gokbulut A, Kartal - Yandim M, Iskender G, et al. Novel agents targeting bioactive sphingolipids for the treatment of cancer [J]. CurrMedChem, 2013,20(1): 108 -122.
  • 9Aoyagi T, Nagahashi M, Yamada A, et al. The role of sphingosine - 1 - phosphate in breast cancer tumor - induced lymphangiogenesis [J]. Lymphat Res Biol, 2012, 10(3) : 97 -106.
  • 10Garris CS, Wu L, Acharya S, et al. Defective sphingosine 1 - phosphate receptor 1 ( S1P1 ) phosphorylation exacerbates TH17 - mediated autoimmune neuroinflammation[ J]. Nat Immunol, 2013, 14(Ii) : 1165-1172.

同被引文献31

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部